These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 18200001

  • 1. T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy.
    Sugano N, Wakino S, Kanda T, Tatematsu S, Homma K, Yoshioka K, Hasegawa K, Hara Y, Suetsugu Y, Yoshizawa T, Hara Y, Utsunomiya Y, Tokudome G, Hosoya T, Saruta T, Hayashi K.
    Kidney Int; 2008 Apr; 73(7):826-34. PubMed ID: 18200001
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of T/L-type calcium channel blockers on tubulointerstitial fibrosis in obstructed kidneys in rats.
    Matsuda H, Mori T, Kurumazuka D, Kitada K, Hayashi T, Nagatoya K, Inoue T, Ukimura A, Matsumura Y, Ishizaka N, Kitaura Y.
    Urology; 2011 Jan; 77(1):249.e9-15. PubMed ID: 21071071
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury.
    Kawabata M, Ogawa T, Han WH, Takabatake T.
    Clin Exp Pharmacol Physiol; 1999 Sep; 26(9):674-9. PubMed ID: 10499155
    [Abstract] [Full Text] [Related]

  • 11. Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive rats.
    Yamamoto E, Kataoka K, Dong YF, Nakamura T, Fukuda M, Nako H, Ogawa H, Kim-Mitsuyama S.
    J Hypertens; 2010 Jun; 28(6):1321-9. PubMed ID: 20224431
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H, Yoshida M, Tojo C, Nakano A, Oshima Y, Kojima Y, Noda K, Wang J, Kobara M, Nakata T.
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [Abstract] [Full Text] [Related]

  • 14. Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine.
    Hayashi K, Saruta T, Goto Y, Ishii M, JATOS Study Group.
    Hypertens Res; 2010 Nov; 33(11):1211-20. PubMed ID: 20844543
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice.
    Kumfu S, Chattipakorn S, Chinda K, Fucharoen S, Chattipakorn N.
    Eur J Haematol; 2012 Jun; 88(6):535-48. PubMed ID: 22404220
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.